Navidea Biopharmaceuticals在盘前交易中暴涨20%,因聘请了Craig A. Dais担任首席财务官。翻译来自ChatGPT查看全文
Navidea生物制药(NAVB)2023-07-14 05:35
$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-23-019901 Act: 34 Size: 199 KB 网页链接查看全文
小水大雨2019-12-31 01:40
$Navidea生物制药(NAVB)$ 未来几天, 估计持续上涨的机率比较大。 但是交易量很低的小盘股, 知适合很小的资金投机一下。 买了200股, 试试运气查看全文
用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-028193 Size: 4 KB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-028197 Size: 6 KB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-028201 Size: 4 KB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-028203 Size: 4 KB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-028188 Size: 4 KB 网页链接
$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-22-027456 Act: 34 Size: 312 KB 网页链接
$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-22-027321 Act: 34 Size: 7 MB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-025390 Size: 4 KB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-025383 Size: 4 KB 网页链接
$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-025385 Size: 4 KB 网页链接